醫(yī)學(xué)微生物學(xué)資料:Pathogenic Fungi_第1頁
醫(yī)學(xué)微生物學(xué)資料:Pathogenic Fungi_第2頁
醫(yī)學(xué)微生物學(xué)資料:Pathogenic Fungi_第3頁
醫(yī)學(xué)微生物學(xué)資料:Pathogenic Fungi_第4頁
醫(yī)學(xué)微生物學(xué)資料:Pathogenic Fungi_第5頁
已閱讀5頁,還剩30頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

1、Pathogenic FungiWhats the difference between fungus and bacteria? what are the factors that may account for the increasing of Mycoses?What are the common themes in the immunity and chemotherapy of fungal diseases?Which factors should be considered when we select (an) antifungal(s) for a patient?33Fu

2、ngus 真菌Hypha /hyphae 菌絲Mycelium 菌絲體Spore 孢子Chitin 幾丁質(zhì)Septa 隔膜,橫膈Septate hyphae 有隔菌絲Aseptate hyphae無隔菌絲Eukaryocyte 真核細(xì)胞Prokaryotic 原核的Ergosterol 麥角固醇Yeast 酵母酵母菌Budding : 芽殖Conidia 分生孢子Ascospore 囊孢子Pseudohypha 假菌絲Granulomatous response 肉芽腫反應(yīng)Pyogenic response 化膿性反應(yīng)Induration 硬化Aflatoxin 黃曲霉素Amanitin 鵝膏

3、菌素Cocidodomycosis球孢子菌病Cryptococcus neoformans 新生隱球菌Opportunistic fungal infection 機(jī)會性真菌感染Primary fungal infection 原發(fā)性真菌感染Candida albicans 白假絲酵母菌 Vocabulary 44Fungus kingdomFungus phylum subphylum Mastigomycotina Zygomycotina接合菌亞門 mucor 毛霉菌 Ascomycotina 子囊菌亞門 histoplasma 組織胞漿菌 Basodopmycotina 擔(dān)子菌亞門 C

4、. neoformans 星形隱球菌 Deutemycotina 半知菌亞門 coccidiodes 球孢子菌55Fungi are everywhere in our daily life 66Fungal diseases are increasingLimits of resolutionClasses of organisms50,000-V electron microscope 0.003mBacteria 0.1-10mMicroscopic protozoa and fungi, 4-40mViruses0.03-0.3mLight microscope 0.2mUnaided

5、 human eye 40mSize (m)Comparison of fungi and bacteriaGeneral Characteristics of FungiSize : varies immensely. bacteria size macroscopically visible size 99Comparison of fungi and bacteria fungi bacteriaSize 4m about 1mNucleus eukaryotic prokaryoticCell membrane sterols no sterolsCell wall chitin PG

6、Spores for reproduction not1010Nucleus :Cytoplasm : Cytoplasmic membrane: ergosterol (麥角固醇)Cell wall : polysacchrides mannan, chitin, -glucanStructure 1111Fibrillar proteinsMannoprotein Glucan Chitin Cytoplasmic membrane The fungi cell wall Hyphae: multicellular branching structures,Mycelium: Integr

7、ated masses of hyphae Each hypha is about 5-10 m wide.myceliumUnicellular fungi multicelluar fungi sporesHyphae of fungiBlastoconidiaAscospores BlastoconidiumPseudohypha Ascus Growth of yeast or yeast-like fungi (budding)Yeast formsVegitative mycelium Nucleus Sporangiospores Arthroconidia Conidia Sp

8、orangia Nucleus Microconidia Macroconidia Conidiophore Nonseptate hyphaChlamydoconidia Ssepta Kenneth J.Ryan/C.Geore Ray. Sherris Medicial Microbiolgy Fourth edition :634Growth of Mold 1616? ? ?Where do those bad guys come from?17171818Airconditioner system1919 person to person transmission animal t

9、o person transmission inhalation from environment endogenous infection. eg. Candiada albicans. Transmission of fungus infectionPrimary pathogensOpportunistic pathogens Candia spp., Aspergillus sppthe state of the host is of primary importanceAttention Pathogenesis of fungusGranulomatous responsePyog

10、enic responseInduration ( delayed hypersensitivity)Toxins like aflatoxin(黃曲霉素), amanitin(鵝膏菌素) Allergic disease ( IgE-mediated hypersensitivityGastrointestinal toxicity Bone marrow toxicityEndocrine toxicity Neurotoxcicity Lung toxicity Allergy Hemorrhage Tumor Hepatoxicity Hepatitis Hepatoma Immune

11、 system toxicityNephrotoxicity Contaminated grain or other food stuffMould in the enviroument Aspergillus sppFusarium sppClaviceps sppPenicillin sppStachybotrys sppMycotoxins in particulatesContact Inhaletion Ingestion Mycotoxins an mycotoxicoses Immunity Humoral immunity Cryptococcus neoformans, ca

12、ndida albicansCoccidioides immitis coccidioidomycosis Cellular immunity Systemic disease :steroid treatment,leukemia, hodgkins disease, and acquired immunodeficiency syndrome.Cell-medicated immunity to fungal infectionsT helper cellCytokines Bound cytokinesInfection of fungusDifferent organisms or s

13、ystems involvedDifferent manifestations subacute to chronic acute diseasesystemic disease26Classification of fungal diseasesSuperficial mycosesCutaneous,hair,and nail mycosesSubcutaneous mycosesSystemic mycoses27Superficial mycosescutaneous, hair, and nail mycosesTinea pedisTinea captis28Subcutaneou

14、s mycosesLaboratory diagnosis Specimen sampling skin , nails,hairs; blood, CSF, sputum and other secretions Microscopy of slide samples 10-20%KOH treatmentDiagnosis CultureMedia: Sabourauds agar , selective mediaTemperature :pH:4.06.0Laboratory diagnosis Serologic tests : To detect fungus antigen or

15、 antibody Molecular biology methods: Based on G+C mol%, RFLP(ristriction fragment length polymorphism ) analysis, Laboratory diagnosis Principles of anti-fungus chemotherapyMost opportunistic fungal infections are self-limited and re-building of normal flora is essential for the infection controlThe

16、 chemotherapy is specially needed for patients with poor immunity Anti-fungal drugs can be applied locally or systemicallyResistance to anti-fungal drugs: concepts are similar to bacteria resistance Principles of anti-fungus Chemotherapy Cell wallInhibitors of Glucan synthesis : Echinocandins:Caspof

17、ungin Inhibitors of chintin synthesis:Nikkomycin Cell membrane Inhibitors of ergosterol synthesis:AzolesAllylamines Direct membrane damage:Polyenes : amphotericin BDisruption of microtubules and inhibition of mitosis :Griseofulvin Nucleic acid synthesis :Flucytosine Inhibition of protein synthesis :SordarinsAzasordarins Sites of acti

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論